(1R,5S)-3-Methyl-3,4,5,6-tetrahydro-1H-1,5-methanopyrido[1,2-a][1,5]diazocin-8(2H)-one, 98%, 5mg

Tert-butyl 3,3-difluoro-4-(4-fluorobenzyl)-3,6-dihydropyridine-1(2H)-carboxylate, 98%, 1g

4-Pentyl-1,1'-Biphenyl, 95.0%, 5g

N-(2-aminoethyl)-4-chlorobenzenesulfonamide, 95.0%, 1g

1-ethyl-1H-indole-2-carboxylic acid, >95%, 500mg

2,2,4,4-TETRAMETHYLTETRAHYDROFURAN, 95%, 250mg

5-Bromochroman-4-one, 95.0%, 250mg

tert-Butyl 7-oxo-2-azaspiro[3.5]nonane-2-carboxylate, 95.0%, 10g

2-[4-(2-Benzimidazolyl)phenyl)]-5-methyl-4-phenylthiazole, 5g

Reaktionsgefäß, DN100, 2,0 l, zylindr.,, gradu., Temp.-Vak.-Mantel, Entleerungsventil., 1 Stück

3-Oxo-3-(4-trifluoromethylphenyl)propionic acid ethyl ester, 95.0%, 5g

Di-tert-butyl (azanediylbis(ethane-2,1-diyl))dicarbamate, 95.0%, 5g

3-Pyridinecarboxamide, N-[4-[(2-amino-3-chloro-4-pyridinyl)oxy]-3-fluorophenyl]-4-ethoxy-1-(4-fluorophenyl)-1,2-dihydro-2-oxo-, 98%, 100mg